Dr. Marina Gilca, MD

Dr. Gilca practices at Medpark Specialized Surgery in Fargo, North Dakota.

Dr. Gilca's NPI, 1386028314, was assigned on July 20, 2015. Dr. Gilca holds North Dakota license 14391.

Dr. Gilca's primary practice is Medpark Specialized Surgery, at 4450 31st Avenue S, STE 201, Fargo, ND 58104. The practice phone is (701) 951-2020.

Dr. Gilca's primary practice is Medpark Specialized Surgery in Fargo, North Dakota. Dr. Gilca is also affiliated with Essentia Health-Fargo. Dmand AI also links Dr. Gilca to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gilca practices, 3 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Gilca's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Gilca is licensed in North Dakota.

CMS data shows 121,485 Medicare services from Dr. Gilca across 31 procedure codes in 2024, for 1,300 Medicare patients. Medicare paid $5,219,652 for them.

CMS counts 1,300 Medicare patients who saw Dr. Gilca in 2024. The largest group is 65 to 74, with 496 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gilca's median patient age at 72, with 54% women.

In 2024, Dr. Gilca wrote 736 Medicare Part D claims for 290 patients. 75% of them were for generic drugs. CMS names the drug for 682 of them, across 14 drugs with 11 or more claims each, at $24,518 in total drug cost. In 2023, CMS named 561 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Gilca for performance year 2024, reported as part of a group. Dr. Gilca accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Gilca. The most frequent topics are Retinal Detachment. Dr. Gilca's most frequent co-authors are Jack A. Cohen, MD, Renaud Duval, MD, FRCSC and Gregg T. Kokame.

CMS Open Payments shows 108 general payments to Dr. Gilca from 17 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 51% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $3,542.